An authoritative technical guide for healthcare procurement directors, orthopedic distributors, and surgical teams seeking high-precision Total Hip Replacement (THA), Hemiarthroplasty systems, and CDSCO/ISO-certified OEM manufacturing.
Combining ISO 13485 certification, advanced metallurgical processing, and in-house sterile manufacturing to redefine orthopedic implant reliability.
When evaluating suppliers for Hip Joint Reconstruction Implants, international medical device distributors and hospital purchasing syndicates require more than standard catalog items. They demand uncompromising quality management systems, rigorous regulatory compliance, traceable raw material sourcing, and scalable manufacturing capabilities. Uteshiya Medicare stands as one of India's premier certified manufacturers and exporters of orthopedic implants, serving clinical demands across 30+ countries.
Our state-of-the-art facility located in Gujarat, India, operates under stringent Cleanroom protocols (Class 10,000 / ISO Class 7 packaging areas). We hold full CDSCO approvals for over 1,000 product lines across joint reconstruction, trauma plates, spinal systems, CMF, external fixators, and sports medicine.
Engineered for biomechanical stability, reduced wear rates, and anatomical fit in primary and revision hip replacement procedures.
Total Hip Arthroplasty (THA) and hip hemiarthroplasty demand reconstructive components that match natural femoral offset, leg length alignment, and acetabular coverage. Uteshiya Medicare offers a fully integrated range of Hip Joint Reconstruction Implants engineered to minimize aseptic loosening, reduce dislocation risks, and promote long-term biological osseointegration.
Designed for primary and complex hip reconstruction. Features proximal plasma-sprayed Titanium porous coating with optional Hydroxyapatite (HA) layer to stimulate rapid bone ingrowth along the metaphyseal region.
Ideal for elderly femoral neck fracture repair. Dual-articulation design features a high-precision CoCrMo outer shell paired with an ultra-high molecular weight polyethylene (UHMWPE) inner bearing to mitigate acetabular erosion.
Hemispherical acetabular shell with multi-hole cluster design for supplementary cancellous screw fixation. Paired with Highly Cross-Linked Polyethylene (XLPE) or Vitamin-E infused liners for zero volumetric wear debris generation.
| Implant Component | Material Standard | Surface Finish / Coating | Fixation Method | Regulatory Status |
|---|---|---|---|---|
| Primary Femoral Stem | Ti-6Al-4V ELI (ISO 5832-3) | Plasma Titanium + Hydroxyapatite (HA) | Press-Fit / Uncemented | CDSCO / ISO 13485 Approved |
| Cemented Femoral Stem | 316L Stainless Steel / CoCrMo | Mirror Polished Metaphyseal Finish | PMMA Bone Cement | CDSCO / ISO 13485 Approved |
| Acetabular Shell | Titanium Porous Foam | Trabecular Porous Structure (Ra 6.3 µm) | Press-Fit with Locking Screws | CDSCO / ISO 13485 Approved |
| Modular Femoral Head | CoCrMo Alloy / Zirconia Ceramic | Ultra-Precision Polished (Ra < 0.02 µm) | 12/14 Morse Taper Interface | CDSCO / ISO 13485 Approved |
| Bipolar Outer Shell | CoCrMo (ISO 5832-4) | Mirror Chrome Finish | Snap-Fit Locking Ring | CDSCO / ISO 13485 Approved |
How international hospital groups, MOH tenders, and implant distributors are reshaping their supply chains.
The global market for hip joint reconstruction is undergoing structural shifts driven by aging demographics, expanding access to healthcare in emerging economies, and persistent cost pressures on public healthcare budgets. For procurement officers and commercial partners, navigating these trends requires aligning with agile manufacturers capable of balancing clinical quality with economic feasibility.
Historically dominated by North American and Western European suppliers, global orthopedic procurement is rapidly diversifying toward certified Indian contract manufacturers. Leading healthcare authorities now recognize that Indian producers like Uteshiya Medicare maintain identical raw material standards (ASTM/ISO certified alloys) and modern CNC Swiss-machining technology at a significantly lower capital cost. This shift allows hospital networks to reduce unit acquisition costs by 30% to 50% without compromising patient outcomes.
Traditional non-sterile implant deliveries require hospitals to run expensive, energy-intensive autoclave sterilization cycles prior to surgery, increasing operating room turnaround times and contamination risk. Procurement managers are increasingly insisting on pre-sterilized, single-pack boxed hip implants with dual-sterile barrier packaging and direct UDI (Unique Device Identification) barcode labeling for immediate hospital inventory tracking.
With the implementation of the European Union Medical Device Regulation (EU MDR 2017/745) and the US FDA Quality Management System Regulation (QMSR), hospital purchasing boards are filtering out non-compliant suppliers. Distributors must partner with manufacturers that maintain comprehensive Technical Master Files, Biocompatibility Reports (ISO 10993), and full batch manufacturing records (BMR) to satisfy local ministry of health registrations in Latin America, Southeast Asia, the Middle East, and Africa.
Exploring advanced bio-materials, additive 3D manufacturing, and robotic-compatible implant geometries.
The clinical science of hip reconstruction is advancing toward personalized joint preservation, extended implant longevity (30+ year survivorship targets), and minimally invasive surgical (MIS) compatibility. As a pioneering manufacturer, Uteshiya Medicare actively integrates these technological innovations into our product design pipelines.
Direct answers to questions frequently asked by international orthopedic buyers and hospital procurement managers.
Expand your commercial portfolio with CDSCO & ISO-certified Total Hip Replacement Systems, Bipolar Stems, and Acetabular Shells. Contact our dedicated orthopedic procurement team today.